Pharmacovigilance and Risk Management Strategies Conference

The use of advanced technologies in the management of chronic diseases is increasing. For example, the use of mobile apps to aid the control of diabetes and the use of wearable technologies to monitor patients health. These technologies are designed to analyze large amounts of data and enable more real time decision-making for patients and their physicians. One example where these technologies are being increasingly used is in the management of diabetes. It is now possible for a patient’s blood glucose to be continually monitored, with the results being analyzed in the cloud and then the patient’s insulin pump being instructed on changes in the insulin infusion rate. Other technologies utilize the cloud to advise patients on bolus insulin doses. These exciting advances, of course, pose questions such as cyber security, who ‘owns’ the data in the cloud, as well as questions for patients, regulators and pharmacovigilance departments – what are the benefits and risks, what are the requirements regarding the collection of AEs, can the data in the cloud be used for signal detection? This session will bring together experts from the scientific and pharmacovigilance fields and patient perspectives to discuss these questions in relation to the management of diabetes.